ClinicalTrials.govpublic full text
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®
neutropenic complications, breast neoplasms, chemotherapy-induced neutropenia, chemotherapeutic toxicity, biosimilars, pegfilgrastim,, g-csf,, neutropenia,, breast cancer,, myelosuppressive chemotherapy,, supportive care, granulocyte-colony-stimulating factor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 918726
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.